Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 349

Similar articles for PubMed (Select 10627470)

1.
2.
3.

Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.

Jourdan M, Mahtouk K, Veyrune JL, Couderc G, Fiol G, Redal N, Duperray C, De Vos J, Klein B.

Eur Cytokine Netw. 2005 Jan-Mar;16(1):57-64.

PMID:
15809207
4.

Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions.

Rutella S, Pierelli L, Bonanno G, Mariotti A, Sica S, Sorà F, Chiusolo P, Scambia G, Rumi C, Leone G.

Exp Hematol. 2001 Dec;29(12):1503-16.

PMID:
11750110
5.
6.

CD40 ligand triggered interleukin-6 secretion in multiple myeloma.

Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC.

Blood. 1995 Apr 1;85(7):1903-12.

7.
8.

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.

Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T.

Blood. 1995 Feb 1;85(3):757-64.

9.

A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA.

J Clin Invest. 1997 Mar 1;99(5):937-43.

10.

Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.

Wallace SR, Oken MM, Lunetta KL, Panoskaltsis-Mortari A, Masellis AM.

Cancer. 2001 Apr 1;91(7):1219-30.

PMID:
11283920
11.
12.

Expression and production of interleukin 10 in human myeloma cell lines.

Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Yawata Y, Ueki A.

Br J Haematol. 2000 Dec;111(3):835-42.

PMID:
11122145
13.

Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2.

Kurowska M, Rudnicka W, Kontny E, Janicka I, Chorazy M, Kowalczewski J, Ziółkowska M, Ferrari-Lacraz S, Strom TB, Maśliński W.

J Immunol. 2002 Aug 15;169(4):1760-7.

14.

Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells.

Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J.

Blood. 1993 Jun 15;81(12):3357-64.

15.
16.

Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2.

Tourkova IL, Yurkovetsky ZR, Gambotto A, Makarenkova VP, Perez L, Balkir L, Robbins PD, Shurin MR, Shurin GV.

J Leukoc Biol. 2002 Nov;72(5):1037-45.

17.

CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.

Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF.

J Immunol. 1994 Jan 1;152(1):117-28.

PMID:
7504707
19.

Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders.

Hata H, Matsuzaki H, Takeya M, Yoshida M, Sonoki T, Nagasaki A, Kuribayashi N, Kawano F, Takatsuki K.

Blood. 1995 Sep 1;86(5):1939-45.

20.

Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity.

Villunger A, Egle A, Kos M, Egle D, Tinhofer I, Henn T, Uberall F, Maly K, Greil R.

Br J Haematol. 1998 Sep;102(4):1069-80.

PMID:
9734660
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk